Impact of non-pharmaceutical interventions on documented cases of COVID-19

Background: The novel coronavirus (SARS-CoV-2) has rapidly evolved into a global epidemic. To control its spread, countries have implemented non pharmaceutical interventions (NPIs), such as school or border closures, while others have even enforced complete lockdowns. Here we study the impact of NPIs in reducing documented cases of COVID-19. Documented case numbers are selected because they are essential for decision-makers in the area of health-policy when monitoring and evaluating current control mechanisms. Methods: We empirically estimate the relative reduction in the number of new cases attributed to each NPI. A cross-country analysis is performed using documented cases through April 15, 2020 from n=20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and Switzerland). Results: As of April 15, venue closures were associated with a reduction in the number of new cases by 36 % (95% credible interval [CrI] 20-48 %), closely followed by gathering bans (34 %; 95% CrI 21-45 %), border closures (31 %; 95% CrI 19-42 %), and work bans on non-essential business activities (31 %; 95% CrI 16-44 %). Event bans lead to a slightly less pronounced reduction (23 %; 95% CrI 8-35 %). School closures (8 %; 95% CrI 0-23 %) and lockdowns (5 %; 95% CrI 0-14 %) appeared to be the least effective among the NPIs considered in this analysis. Conclusions: With this cross-country analysis, we provide early estimates regarding the impact of different NPIs for controlling the COVID-19 epidemic. These findings are relevant for evaluating current health-policies. Keywords: COVID-19, coronavirus, non-pharmaceutical interventions, policy measures, health-policy, public health, health services research

[1]  D. Rubin,et al.  Inference from Iterative Simulation Using Multiple Sequences , 1992 .

[2]  Jiqiang Guo,et al.  Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.

[3]  Aki Vehtari,et al.  Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC , 2015, Statistics and Computing.

[4]  Haoyang Sun,et al.  Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study , 2020, The Lancet Infectious Diseases.

[5]  Agata Mikolajczyk,et al.  The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China , 2020, Journal of travel medicine.

[6]  D. Brockmann,et al.  Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China , 2020, Science.

[7]  A. Vespignani,et al.  Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study , 2020, The Lancet Infectious Diseases.

[8]  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[9]  L. Meyers,et al.  Serial Interval of COVID-19 among Publicly Reported Confirmed Cases , 2020, Emerging infectious diseases.

[10]  Carl A. B. Pearson,et al.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.

[11]  Yang Liu,et al.  Early dynamics of transmission and control of COVID-19: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[12]  S. Bhatt,et al.  Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .

[13]  G. Ippolito,et al.  Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma , 2020, The Lancet.

[14]  S. Bhatt,et al.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.

[15]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[16]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19) , 2020, medRxiv.

[17]  B. Singer,et al.  Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak , 2020, Proceedings of the National Academy of Sciences.

[18]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[19]  H. Croker,et al.  School Closure and Management Practices During Coronavirus Outbreaks Including COVID-19: A Rapid Narrative Systematic Review , 2020 .

[20]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[21]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[22]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak , 2020, medRxiv.

[23]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[24]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[25]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[26]  W. Liang,et al.  Clinical characteristics of 2019 novel coronavirus infection in China , 2020, medRxiv.

[27]  G. Leung,et al.  First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment , 2020, The Lancet.

[28]  P. Klepac,et al.  The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China , 2020, medRxiv.

[29]  E. Holmes,et al.  Author Correction: A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[30]  C. Fraser,et al.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, medRxiv.

[31]  D. Brockmann,et al.  Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China , 2020, Science.

[32]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[33]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[34]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.

[35]  Xihong Lin,et al.  Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. , 2020, JAMA.

[36]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[37]  R. Viner,et al.  School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review , 2020, The Lancet Child & Adolescent Health.

[38]  Peng Wu,et al.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study , 2020, The Lancet Public Health.

[39]  Ruifu Yang,et al.  An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China , 2020, Science.

[40]  Nuno R. Faria,et al.  The effect of human mobility and control measures on the COVID-19 epidemic in China , 2020, Science.

[41]  Zheng Zhao,et al.  Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures , 2020, The Lancet.